跳至主要内容
临床试验/NCT00469573
NCT00469573已完成4 期

Safety and Efficacy of Optive in Contact Lens Wearers With Dry Eyes

Innovative Medical1 个研究点 分布在 1 个国家目标入组 36 人开始时间: 2007年5月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
入组人数
36
试验地点
1
主要终点
Safety

研究概览

简要总结

The purpose of this study is to determine if Optive®eye drops are safe for people who wear contact lenses and have dry eyes. The second goal of the study is to determine if using Optive®eye drops can improve my dry eye scores on a standard dry eye test (called the OSDI).

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Single Group
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Men and women 18 and over
  • Self-reported use of daily-wear soft contact lenses that have been a proper fit for at least one month prior to the screening visit.
  • Complaint of dry eyes
  • OSDI score > 23

排除标准

  • Use of RGP or PMMA contact lenses
  • Poorly fitting contact lenses
  • Concurrent ocular conditions or pathology that could affect contact lens fit or patient's ability to complete study
  • Concurrent use of topical medications other than study medications
  • Use of systemic medications with ocular drying sequelae:
  • Antihistamines
  • Decongestants
  • Antispasmotics Antidepressants Change in contact lens care solutions within the prior 30 days

研究组 & 干预措施

1.

Other

干预措施: 1. Optive (Drug)

结局指标

主要结局

Safety

时间窗: 8 months

次要结局

  • Efficacy(8 months)

研究者

申办方类型
Industry

研究点 (1)

Loading locations...

相似试验